oxaprozin
英
美
网络 奥沙普秦; 奥沙普嗪; 噁丙嗪; 恶丙嗪; 诺松
双语例句
- To establish fluorescent method for the determination of oxaprozin enteric-coated capsules.
目的：建立奥沙普嗪肠溶胶囊的荧光测定法。 - Objective To establish a HPLC method for determining the concentration of oxaprozin in human plasma.
目的建立奥沙普嗪血药浓度的高效液相色谱法（HPLC法）。 - Three aspects of Oxaprozin are discussed in this article, Which inclnde the optimum design of reaction conditions, purification of the find product and preparation of the Calcium Salt.
本文讨论了（口恶）丙嗪合成条件的优化设计，产品的纯制方法及钙盐的制备方法。 - Objective: To study the influence of oxaprozin on platelet aggregation and thrombosis in rabbits and rats.
目的：研究奥沙普嗪对家兔和大鼠血小板聚集和血栓形成的影响。 - Objection: To determinate oxaprozin by colorimetric method.
目的：用比色法测定奥沙普嗪的含量。 - OBJECTIVE: To prepare oxaprozin dispersible tablets, and the dissolution rate of it was compared with the other two commericial tablets.
目的：制备卟恶丙嗪分散片，并将其与另两种市售片剂的溶出度进行比较。 - Objective: To determinate oxaprozin and its tablet.
前言：目的：测定奥沙普秦及其片剂的含量。 - Aim An HPLC method was established for the study on pharmacokinetics and bioequivalence of oxaprozin enteric tablet in healthy volunteers.
目的建立一种HPLC检测法，以测定人体血浆中奥沙普秦的药物浓度，并对两种奥沙普秦肠溶片生物等效性进行评价。 - Objective: To determine the content of oxaprozin.
目的：测定奥沙普秦含量。 - OBJECTIVE To establish a method of nonaqueous capillary electrophoresis ( NACE) to separate non-steroidal anti-inflammatory drugs ( NSAIDs) and determine the content of oxaprozin in enteric-coated tablet.
目的建立一种非水毛细管电泳法（NACE）分离非甾体抗炎药物，并对奥沙普秦肠溶片进行定量分析。 - Study on pharmacodynamics and permeation of oxaprozin gel in vitro
奥沙普秦凝胶剂的体外渗透性及药效学 - Study on assay method of oxaprozin in its liniment was reported.
本文报道呕恶丙嗪擦剂含量测定方法学的研究。 - METHODS: The permeation and release of oxaprozin gel was measured by using Franz diffusion cell.
方法：采用Franz扩散池，进行奥沙普秦凝胶剂体外渗透性和释放度实验。 - Determination of Oxaprozin and its Tablets by HPLC
奥沙普秦及其片剂的HPLC测定 - Preparation and determination of Oxaprozin gel
恶丙嗪凝胶剂的制备及含量测定 - RESULTS: The ex vivo permeability of oxaprozin gel was the best when the carbomer 940 used as its base material with its ex vivo permeability coefficient at 22.77 μ g/ ( cm2 · h).
结果：以卡波姆940为基质的奥沙普秦凝胶体外渗透系数为22.77／μg／（cm2·h），其体外渗透性最佳。 - Conclusion: The method is used to determine the content of oxaprozin tablet and raw material medicine, which is simple, rapid, qualitative, accurate with satisfactory results.
结论：该法快速准确、操作方便，用于样品及原料药中的奥沙普秦的含量测定，结果令人满意。 - Phase III trials of oxaprozin enteric coated tablet in treatment of rheumatoid arthritis
奥沙普秦肠溶片治疗类风湿关节炎的III期临床试验 - Study on Stability and Prescription Screening of Oxaprozin Gel
奥沙普秦凝胶剂处方筛选及稳定性研究 - Studies on Solubility of Oxaprozin
恶丙嗪溶解性能的研究 - The bioequivalence of oxaprozin enteric tablet in healthy volunteers measured with HPLC
奥沙普秦肠溶片HPLC测定法及其人体生物等效性研究 - CONCLUSIONS The results showed that the percutaneous absorption of Oxaprozin was a zero-order releasing kinetics through nonpolar channel, and 10% oleic acid plus 1% azone was the most effective one.
结论：奥沙普秦透皮吸收符合非极性通道释放的零级动力学方程，其中以10%油酸加1%月桂氮芯卓酮组成的混合促进剂作用最显著。 - Determination of Oxaprozin Gel by HPLC
奥沙普秦凝胶剂的HPLC测定 - OBJECTIVE To prepare the complex between oxaprozin and hydrogenated phospholipid.
目的制备奥沙普秦氢化磷脂复合物。 - Objective: To prepare oxaprozin liposome.
目的：制备恶丙嗪脂质体。 - OBJECTIVE: To compare the relative bioavailability of 2 kinds of domestic oxaprozin enteric tablets.
目的：比较2种国产奥沙普秦肠溶片的相对生物利用度。 - RESULTS The oxaprozin-PEG 6000 solid dispersion was a simple-lower-eutectic compound. The oxaprozin was dispersed in PEG 6000 as micro-crystallite form.
结果：卟恶丙嗪PEG6000固体分散体是一种简单低共熔混合物，卟恶丙嗪以超细结晶状态分散在PEG载体中。 - Objective To synthesize nonsteroidal anti-inflammatory drug oxaprozin.
目的合成非甾体类抗炎药奥沙普秦。